Community Pharmacy Integration was a pilot study conducted by NHS England East of England Region from November 2022 to December 2023 across the East of England. The pilot gave selected community pharmacies a TPP SystmOne Community Unit (SystmOne) giving them full read and write access to consenting patients’ primary care records. The pilot was intended to improve communication and integrated working between community pharmacies and general practice.
We evaluated the feasibility, acceptability and impact of providing community pharmacies with read-and-write access to a shared EHR (SystmOne) used in general practice across selected sites in the East of England, in the same way other health professionals do including community nursing teams and staff within Primary Care Networks (PCNs). The evaluation report was completed at the end of 2024.
The evaluation was a collaboration between the evaluation team at Health Innovation East; academic experts, Hamde Nazar Professor of Pharmacy at Newcastle University and Michael Twigg Associate Professor at the University of East Anglia; and the NHS England East of England Regional project team who were responsible for implementing the pilot.
“Community pharmacies play a vital role in society, and they are a hugely important part of the healthcare sector in England. Like GPs, pharmacies are a part of the extended NHS family. Anyone can visit their local pharmacy to access medicines, healthcare advice and a range of other health services.”(1)
In 2022, the Professional Record Standards Body (PRSB) (2) reported on the importance of community pharmacists having full read-and-write access to patient’s healthcare records, identifying:
The importance of providing integrated, real-time digital communication between care settings and healthcare professionals to ensure community-based care is coordinated, safe and effective, and work such to evaluate these changes is further highlighted by recent shifts, including:
Findings from this pilot highlight key considerations for future developments and provide a foundation for policy and practice discussions aimed at leveraging digital integration to enhance community-based healthcare delivery.
Health Innovation East led the evaluation for this pilot. A mixed methods approach was used to understand how and to what extent community pharmacies utilised the EHR system. The evaluation also explored the perceived impact and acceptability of this new way of working for community pharmacy and general practice as well as identifying any issues, considerations and improvements for future deployments of EHR systems in community pharmacy.
We analysed records of usage of the system by the community pharmacies that participated to measure the uptake and impact of the pilot. We gathered insights from staff in the participating pharmacies and their associated general practices through surveys and interviews at the start and towards the end of the 12 month pilot (pre- and post-implementation).
The pilot demonstrated that the shared access and functionality of an EHR can improve integrated working and service delivery.
A total of 35 community pharmacies and 19 general practices actively used SystmOne to share and record information throughout the pilot. These practices booked over 19,000 patients into community pharmacy appointments directly through the system. 13 pharmacies actively used SystmOne to directly record over 16,000 patient consultations and clinical interactions, using templates and clinical coding aligned with general practice standards.
Staff reported enhanced interprofessional communication, improved clinical decision-making, and better service coordination, all contributing to enhanced quality and safety of patient care.
“It significantly reduced our time contacting GPs. I’m not looking for email addresses, I’m not sending it to an old practice manager. I get it tasked to the right team and then it gets actioned.” (P04)
“So we have embedded SystmOne into our like daily practice. So now we pretty much can’t live without it […]. So it has been a real game changer, changed our practice completely. We have expanded and excelled our clinical services because of this, it is just great.” (P04)
The use of SystmOne reduced the need for additional communication channels, such as NHS mail, provided real-time documentation, and reduced duplication – streamlining workflows, improving efficiency and reducing administrative burden for both sectors.
The pilot also highlighted areas for consideration in adoption and scale up:
Hospital to community – Community pharmacy is an essential partner in achieving this reform. By enabling community pharmacies to have full access and autonomy to record directly in the patient’s health care record in parity with other clinical colleagues is critical.
Analogue to digital -Digital integration is a key facilitator to improve communication and coordination of care between general practice and community pharmacy, and enabler to improve community pharmacy’s integration into the wider healthcare system (7-9).
Whilst broader adoption requires addressing interoperability, system usability, and policy alignment, scaling such initiatives may support the evolving clinical role of community pharmacists.
These findings can be applied to help inform future initiatives, and these have been mobilised through reporting and the NHS East of England regional project leads. Many of the pharmacies that participated in the pilot felt strongly about the need to retain access beyond the pilot.
I think unreservedly, we wouldn’t go back. We are very keen to keep SystmOne as the combined platform going forward, and we would really encourage community pharmacies to explore this because I think it enables the policy agenda of working together to support patients. And so we would highly recommend engagement with this.
Access the evaluation report here
References:
(1) Community Pharmacy England. Pharmacy: the heart of our community 2025
(2) The Professional Record Standards Body. Use of the Core Information Standard in community settings: pharmacy, dentistry, optometry, ambulance and community services. The Professional Record Standards Body; 2022. p. 1-68.
(3) Uppal Z, Jones S, Fernandes R. xploring enablers and barriers to pharmacists becoming designated prescribing practitioners. Journal of Prescribing Practice. 2024;6(9):382-92.
(4) NHS England. National Health Service (Pharmaceutical and Local Pharmaceutical Services) ) Regulations 2013. The Stationary Office Limited 2013.
(5) NHS England PSNC. The community pharmacy contractual framework for 2019/20 to 2023/24: Supporting delivery for the NHS long term plan. NHS England: London, UK. 2019:26.
(6) Darzi A. Independent investigation of the national health service in England: Department of Health and Social Care; 2024.
(7) Barata J, Maia F, Mascarenhas A. Digital transformation of the mobile connected pharmacy: a first step toward community pharmacy 5.0. Informatics for Health and Social Care. 2022;47(4):347-60.
(8) Owen-Boukra E, Cai Z, Duddy C, Fudge N, Hamer-Hunt J, Husson F, et al. Collaborative and integrated working between general practice and community pharmacies: A realist review of what works, for whom, and in which contexts. Journal of Health Services Research & Policy. 2025;30(2):136-48.
(9) Weissenborn M, Haefeli WE, Peters-Klimm F, Seidling HM. Interprofessional communication between community pharmacists and general practitioners: a qualitative study. International journal of clinical pharmacy. 2017;39:495-506.
Do you have a great idea that could deliver meaningful change in the real world?
Get involved